STX-0119
STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an IC50 of 74 μM[1].
Product Specifications
CAS Number
[851095-32-4]
UNSPSC
12352005
Target
STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/stx-0119.html
Concentration
10mM
Purity
98.40
Solubility
DMSO : 13.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC(C2=CC=CC=C2)=NC3=C1C=CC=C3)NC4=NN=C(C5=CC=CO5)O4
Molecular Formula
C22H14N4O3
Molecular Weight
382.37
References & Citations
[1]Matsuno K, et al. Identification of a New Series of STAT3 Inhibitors by Virtual Screening. ACS Med Chem Lett. 2010 Jul 13;1 (8) :371-5.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
STAT3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL316923V 500 µL Each
Peroxiredoxin 4 (PRDX4) Human shRNA Lentiviral Particle (Locus ID 10549)
Ask
View Details 036305-PE 200 µL
GRIN3B, CT (GRIN3B, Glutamate [NMDA] receptor subunit 3B, N-methyl-D-aspartate receptor subtype 3B) (PE) discontinued
Ask
View Details